Do Analysts Like Or Dislike Omega Healthcare Investors, Inc. (OHI) and MetLife, Inc. (MET)

Looking at top Wall Street opinions, Omega Healthcare Investors, Inc. (NYSE: OHI) has recently made its way into the research list of Raymond James – signaling that their analyst’s rating adjustment is noteworthy. This stock was upgraded to a rating of Strong Buy in the eyes of Raymond James, whereas its previous rating was Outperform in the eyes of Raymond James, as reported on Thursday, August 8th, 2019. Another heavy-hitting research note was published by Stifel on Thursday February 7th, 2019, with this firm downgrading OHI to an updated rating of Hold from its previous rating of Buy. In the past six months and three months of trading, shares of Omega Healthcare Investors, Inc. (OHI) have moved by 5.50% and 1.92%, respectively.

Brokerage Updates Related to Omega Healthcare Investors, Inc. (OHI) Stock

This publicly-traded organization generated gains of 4.80% over the last 5 sessions. Right now, this stock is the subject of 9 analysts’ evaluations, who – on average – have given this company’s shares a Buy rating. Not a Single analyst have given underperform rating or sell rating, and 0 have given a rating of Buy or better. Based on the 9 stock market experts following this company, the average 12-month price target is $37.75. Moreover, individual price targets range between $34.00-$42.00. With its recent move to $37.00, we can see that these firms project this stock will gain by 21.24% in one year.

Updates from Omega Healthcare Investors, Inc. (OHI) SEC Form 4

This particular company’s shares have garnered a lot of attention in recent days, as insiders are unloading their holdings while having generated a 0.50% rise since the beginning of the calendar year. A Chief Executive Officer at Omega Healthcare Investors, Inc. (OHI) sold off some of its shares in a transaction that was finalized on Jul 09. Similarly, PICKETT C TAYLOR sold 5,500 shares of the organization’s stock at $38.00 apiece and racked up $209,000 in earnings from the sale. Now, PICKETT C TAYLOR holds 227,933 shares of the company following the exchange. A Chief Executive Officer of the organization named PICKETT C TAYLOR, was engaged in a transaction that occurred on Jun 25 that managed to be worth $216,600 from the sale of 5,700 common shares at a price of $38.00 per individual share.

Omega Healthcare Investors, Inc. (NYSE:OHI) Results in the Pipeline

The next scheduled release of financial results for Omega Healthcare Investors, Inc. will be for the Mar-19 quarter. In the same vein, they expect sales for the quarter to amount to $220.24 million.

Now let’s turn to earnings surprise history: in the most recent quarter, the company reported about $223.69 million. On average, the analyst projection was calling for $219.75 million. In the preceding quarter, this company’s revenue reached $221.85 million.

MetLife, Inc. (NYSE:MET) experienced a drop of -4.39% from the closing price in the previous trading day. That drove the price to $44.87 per share, as observed on January 1st, 1970, at a time when the total trading volume reached 9,580,318 shares of stock – compared to the typical average of 4.65M shares per day (as recorded over the past three months). The consensus estimate for these shares has been shifted to $53.53.

Pricing Indications for MetLife, Inc. (MET)

This organization has had a price-to-earnings ratio of 7.38 in the last year. Meanwhile, it gained 48.98 from its observable 50-day simple moving average. Right at this moment, the per-share value is -1.16% lower than the mean per-share price over the last 200 days in the market.

MetLife, Inc. (NYSE:MET) In-Depth Brokerage Insights

We can see that a number of brokerage firms are putting their focus onto this stock. Out of this group, 1 have a sell rating, 5 have a Buy rating, 5 have an outperform rating, while 8 provided a Hold rating for these shares – thanks to data from Thomson Reuters I/B/E/S. Additionally, 0 have recommended that these shares are an Underperforming investment. The current consensus recommendation is at 2.40, based on information from Thomson Reuters.

MET Stock Value Potential

In trading activity as of late, this stock’s value was 45.42 up from its 200 day moving average, while also -8.50% down when compared against its 50-day simple moving average. Over the course of the past year of trading, the share price stuck in the range of $42.00-$63.00. The market value for the entire organization reached 42.25B. In the last trading session, the price ended the day at $46.93. The institutional holdings related to this organization account for 0.10%, and the Beta factor is now 1.09. This company’s RSI (Relative Strength Index) managed to hit 33.52.

MetLife, Inc. (NYSE:MET) Analyst Points of Focus

MetLife, Inc. (MET) has found itself inside of Evercore ISI’s research list, so their analyst rating adjustment is worth taking note of. This stock was downgraded to In-line, compared to its previous rating of Outperform by Evercore ISI, as garnered from a news report on Tuesday July 16th, 2019. An additional helpful research note was sent out by Sandler O’Neill’s on Tuesday March 19th, 2019. The brokerage decided to downgrade MET to Hold from its previous rating of Buy.